Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The Elusive but Painful Subtalar Joint in Rheumatoid Arthritis.

Kaeley GS, Ranganath VK, Roth J.

J Rheumatol. 2019 Apr;46(4):333-336. doi: 10.3899/jrheum.181156. No abstract available.

PMID:
30936222
2.

Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate.

Kaeley GS, MacCarter DK, Pangan AL, Wang X, Kalabic J, Ranganath VK.

J Rheumatol. 2018 Dec;45(12):1628-1635. doi: 10.3899/jrheum.171232. Epub 2018 Sep 1.

PMID:
30173153
3.

Chasing the Ghost of Imaging Remission in Rheumatoid Arthritis.

Kaeley GS, Ranganath VK.

J Rheumatol. 2018 Jul;45(7):881-883. doi: 10.3899/jrheum.180035. No abstract available.

PMID:
29961675
4.

Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis.

Charles-Schoeman C, Gugiu GB, Ge H, Shahbazian A, Lee YY, Wang X, Furst DE, Ranganath VK, Maldonado M, Lee T, Reddy ST.

Atherosclerosis. 2018 Aug;275:107-114. doi: 10.1016/j.atherosclerosis.2018.04.003. Epub 2018 Apr 17.

5.

Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients.

Ranganath VK, Duffy EL, Garg VK, Woodworth T, Taylor M, Paulus HE, Altman RD, Elashoff DA.

J Clin Rheumatol. 2019 Apr;25(3):e8-e11. doi: 10.1097/RHU.0000000000000799.

PMID:
29683839
6.

Ultrasound characterization of cutaneous ulcers in systemic sclerosis.

Suliman YA, Kafaja S, Fitzgerald J, Wortsman X, Grotts J, Matucci-Cerrinic M, Ranganath VK, Furst DE.

Clin Rheumatol. 2018 Jun;37(6):1555-1561. doi: 10.1007/s10067-018-3986-5. Epub 2018 Mar 10.

PMID:
29525847
7.

Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review.

Woodworth TG, Morgacheva O, Pimienta OL, Troum OM, Ranganath VK, Furst DE.

Rheumatology (Oxford). 2017 Jul 1;56(7):1177-1188. doi: 10.1093/rheumatology/kew445. Review.

8.

Joint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patients.

Bauer EM, Ben-Artzi A, Duffy EL, Elashoff DA, Vangala SS, Fitzgerald J, Ranganath VK.

BMC Musculoskelet Disord. 2017 Mar 4;18(1):99. doi: 10.1186/s12891-017-1406-7.

9.

Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials.

Peterfy C, Strand V, Tian L, Østergaard M, Lu Y, DiCarlo J, Countryman P, Deodhar A, Landewé R, Ranganath VK, Troum O, Conaghan PG.

Ann Rheum Dis. 2017 Jun;76(6):992-997. doi: 10.1136/annrheumdis-2016-210311. Epub 2016 Dec 14.

PMID:
27974302
10.

Importance of 'meeting of the minds': patient-reported outcomes and MRI.

Ranganath VK, Strand V.

Ann Rheum Dis. 2017 Mar;76(3):473-475. doi: 10.1136/annrheumdis-2016-210058. Epub 2016 Sep 29. No abstract available.

PMID:
27689734
11.

Elevated baseline power Doppler discriminates an RA subgroup highly responsive to therapy.

Ranganath VK, Ben-Artzi A, Duffy E, Brook J, Taylor M, Choi S, Paulus H, Elashoff DA.

Rheumatology (Oxford). 2015 Dec;54(12):2285-6. doi: 10.1093/rheumatology/kev301. Epub 2015 Aug 27. No abstract available.

12.

Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy.

Ranganath VK, Motamedi K, Haavardsholm EA, Maranian P, Elashoff D, McQueen F, Duffy EL, Bathon JM, Curtis JR, Chen W, Moreland L, Louie J, Amjadi S, O'Dell J, Cofield SS, St Clair EW, Bridges SL Jr, Paulus HE.

Arthritis Care Res (Hoboken). 2015 Jul;67(7):929-39. doi: 10.1002/acr.22541.

13.

Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.

Martin WJ, Shim M, Paulus HE, Chaudhari S, Feng J, Elashoff D, Hahn TJ, Ranganath VK; RADIUS Investigators.

J Clin Rheumatol. 2014 Sep;20(6):301-5. doi: 10.1097/RHU.0000000000000152.

14.

Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis.

Charles-Schoeman C, Lee YY, Shahbazian A, Gorn AH, Fitzgerald J, Ranganath VK, Taylor M, Ragavendra N, McMahon M, Elashoff D, Reddy ST.

Arthritis Rheum. 2013 Nov;65(11):2765-72. doi: 10.1002/art.38118.

15.

Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.

Ranganath VK, Maranian P, Elashoff DA, Woodworth T, Khanna D, Hahn T, Sarkisian C, Kremer JM, Furst DE, Paulus HE.

Rheumatology (Oxford). 2013 Oct;52(10):1809-17. doi: 10.1093/rheumatology/ket224. Epub 2013 Jun 27.

16.

Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.

O'Dell JR, Curtis JR, Mikuls TR, Cofield SS, Bridges SL Jr, Ranganath VK, Moreland LW; TEAR Trial Investigators.

Arthritis Rheum. 2013 Aug;65(8):1985-94. doi: 10.1002/art.38012.

17.

Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.

Curtis JR, McVie T, Mikuls TR, Reynolds RJ, Navarro-Millán I, O'Dell J, Moreland LW, Bridges SL Jr, Ranganath VK, Cofield SS.

J Rheumatol. 2013 May;40(5):572-8. doi: 10.3899/jrheum.120715. Epub 2013 Apr 15.

18.

Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.

Doyle MK, Rahman MU, Frederick B, Birbara CA, de Vries D, Toedter G, Wu X, Chen D, Ranganath VK, Westerman ME, Furst DE.

Rheumatology (Oxford). 2013 Jul;52(7):1214-9. doi: 10.1093/rheumatology/kes381. Epub 2013 Feb 14.

PMID:
23418046
19.

Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.

Jawaheer D, Messing S, Reed G, Ranganath VK, Kremer JM, Louie JS, Khanna D, Greenberg JD, Furst DE.

Arthritis Care Res (Hoboken). 2012 Dec;64(12):1811-8. doi: 10.1002/acr.21762.

20.

Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis.

Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald JD, Ranganath VK, Nicassio PM.

Sleep. 2012 Apr 1;35(4):537-43. doi: 10.5665/sleep.1742.

21.

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK, Taylor M, McMahon M, Paulus HE, Reddy ST.

Ann Rheum Dis. 2012 Jul;71(7):1157-62. doi: 10.1136/annrheumdis-2011-200493. Epub 2012 Jan 20.

22.

Differences in presentation of younger and older systemic sclerosis patients in clinical trials.

Weng HH, Ranganath VK, Oh M, Park GS, Khanna D, Clements PJ, Seibold JR, Elashoff DA, Furst DE.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S10-4. Epub 2010 Nov 3.

23.

Remission in rheumatoid arthritis.

Shammas RM, Ranganath VK, Paulus HE.

Curr Rheumatol Rep. 2010 Oct;12(5):355-62. doi: 10.1007/s11926-010-0121-2. Review.

24.

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.

Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG.

Arthritis Care Res (Hoboken). 2010 Nov;62(11):1515-26. doi: 10.1002/acr.20295. Epub 2010 Jul 26. Review. No abstract available. Erratum in: Arthritis Care Res (Hoboken). 2012 Mar;64(3):464.

25.

Through the looking glass: "remission" in rheumatoid arthritis.

Ranganath VK.

J Rheumatol. 2010 Jul;37(7):1371-3. doi: 10.3899/jrheum.100495. No abstract available.

PMID:
20595289
26.

Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.

Weng HH, Ranganath VK, Khanna D, Oh M, Furst DE, Park GS, Elashoff DA, Sharp JT, Gold RH, Peter JB, Paulus HE; Western Consortium of Practicing Rheumatologists.

J Rheumatol. 2010 Mar;37(3):550-7. doi: 10.3899/jrheum.090818. Epub 2010 Jan 28.

27.

Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited systemic sclerosis.

Wong M, Ranganath VK, Clements PJ.

J Rheumatol. 2010 Jan;37(1):214-5. doi: 10.3899/jrheum.090154. No abstract available.

28.

Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry.

Furst DE, Chang H, Greenberg JD, Ranganath VK, Reed G, Ozturk ZE, Kremer JM.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4):560-6.

PMID:
19772785
29.

Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis.

Amjadi SS, Maranian PM, Paulus HE, Kaplan RM, Ranganath VK, Furst DE, Khanna PP, Khanna D; Western Consortium of Practicing Rheumatologists.

J Rheumatol. 2009 Jun;36(6):1150-7. doi: 10.3899/jrheum.080959. Epub 2009 Apr 15.

30.

Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database.

Ranganath VK, Paulus HE, Onofrei A, Khanna D, Reed G, Elashoff DA, Kremer JM, Furst DE.

J Rheumatol. 2008 Oct;35(10):1966-71. Epub 2008 Sep 1.

31.

Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort.

Ranganath VK, Yoon J, Khanna D, Park GS, Furst DE, Elashoff DA, Jawaheer D, Sharp JT, Gold RH, Keystone EC, Paulus HE; Western Consortium of Practicing Rheumatologists.

Ann Rheum Dis. 2007 Dec;66(12):1633-40. Epub 2007 May 1.

32.

Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.

Ranganath VK, Furst DE.

Rheum Dis Clin North Am. 2007 Feb;33(1):197-217. Review.

PMID:
17367700
33.

ACR remission criteria and response criteria.

Ranganath VK, Khanna D, Paulus HE.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-14-21. Review.

PMID:
17083757
34.

Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage.

Khanna D, Ranganath VK, Fitzgerald J, Park GS, Altman RD, Elashoff D, Gold RH, Sharp JT, Furst DE, Paulus HE; Western Consortium of Practicing Rheumatologists.

Arthritis Rheum. 2005 Aug;52(8):2284-92.

35.

Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.

Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE; Western consortium of practicing rhuemotologists.

J Rheumatol. 2005 Jun;32(6):1040-2.

PMID:
15940764
36.

Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.

Ranganath VK, Furst DE.

Clin Geriatr Med. 2005 Aug;21(3):649-69, viii. Review.

PMID:
15911212

Supplemental Content

Loading ...
Support Center